Skip to main content
. 2022 Oct 6;14(19):4151. doi: 10.3390/nu14194151

Table 2.

Anthropometrics and medical data of the participants.

Total Population
n (%) 2
Women
n (%)
Men
n (%)
1082 (100) 804 (74.3) 278 (25.7)
Age (years) 1 32.5 12.0 31.1 10.8 36.5 14.2
Weight (kg) 1 71.1 15.2 67.8 13.9 80.5 14.8
Height (m) 1 1.68 0.08 1.64 0.06 1.77 0.06
BMI (kg/m2) 1 25.1 4.9 25.0 5.0 25.4 4.4
Nutritional status 2 p = 0.20 3
Underweight 60 (5.5) 50 (6.2) 10 (3.6)
Normal weight 528 (48.8) 396 (49.2) 132 (47.5)
Preobese 337 (31.1) 241 (30.0) 96 (34.5)
Obese 157 (14.5) 117 (14.6) 40 (14.4)
History of chronic diseases (number of diseases) 2 p = 0.20 3
No chronic disease 852 (78.7) 632 (78.6) 220 (79.1)
One disease 195 (18.0) 143 (17.8) 52 (18.7)
Multiple diseases 35 (3.2) 29 (3.6) 6 (2.1)
History of chronic diseases (type of diseases) 2 p = 0.002 3
Cardiovascular diseases 25 (10.9) 14 (8.1) 11 (19.0)
Endocrine, nutritional, or metabolic diseases 56 (24.3) 37 (21.5) 19 (32.7)
Respiratory and ENT diseases 14 (6.1) 8 (4.6) 6 (10.3)
Digestive diseases 13 (5.7) 12 (7.0) 1 (1.7)
Hematological diseases 26 (11.3) 26 (15.1) 0 (0.0)
Genecology, urinary and kidney diseases 9 (3.9) 5 (2.9) 4 (6.8)
Cancer 2 (0.9) 2 (1.2) 0 (0.0)
Other diseases 50 (21.7) 39 (22.7) 11 (19.0)
Morbid health status (more than 3 diseases) 35 (15.2) 29 (16.9) 6 (10.3)
Diet 2 p = 0.004 3
Spontaneous feeding with no diet 960 (88.7) 713 (88.7) 247 (88.8)
Healthy diet 23 (2.1) 15 (3.2) 8 (1.4)
Weight-loss diet 34 (3.1) 29 (3.6) 5 (1.8)
Reduced sugar/salt diet 20 (1.8) 8 (1.0) 12 (4.3)
Therapeutic diet 13 (1.2) 11 (1.4) 2 (0.7)
Vegetarian diet 2 (0.2) 2 (0.2) 0 (0.0)
Not specified 30 (2.8) 26 (3.2) 4 (1.4)
Incidence of COVID-19 2 p = 0.55 3
Not exposed 734 (67.8) 539 (67.0) 195 (70.1)
Suspected infection 168 (15.5) 132 (16.4) 36 (12.9)
Mid-form infection 167 (15.4) 124 (15.4) 43 (15.5)
Severe form infection 13 (1.2) 9 (1.1) 4 (1.4)
Occurrence of family death due to COVID-19 2 p = 0.90 3
No 886 (81.9) 659 (82.0) 227 (81.6)
Yes 196 (18.1) 145 (18.0) 51 (18.4)
Vaccination against COVID-19 2 p = 0.14 3
No 847 (78.3) 638 (79.3) 209 (75.2)
Yes 235 (21.7) 166 (20.7) 69 (24.8)

1 Data are expressed as means with standard deviation in separate columns. 2 Data are expressed as total number of respondents with proportions between brackets for categorical variables. 3 p-value: null hypothesis of same distribution between both sexes (chi-squared and Fisher exact test); null hypothesis rejected at p < 0.05.